Form 8-K - Current report:
SEC Accession No. 0001493152-24-006873
Filing Date
2024-02-15
Accepted
2024-02-15 16:15:33
Documents
18
Period of Report
2024-02-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45937
2 ex99.htm EX-99 28595
3 ex99_001.jpg GRAPHIC 3440
4 ex99_002.jpg GRAPHIC 2780
  Complete submission text file 0001493152-24-006873.txt   311445

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hrow-20240215.xsd EX-101.SCH 3944
6 XBRL DEFINITION FILE hrow-20240215_def.xml EX-101.DEF 26962
7 XBRL LABEL FILE hrow-20240215_lab.xml EX-101.LAB 37183
8 XBRL PRESENTATION FILE hrow-20240215_pre.xml EX-101.PRE 25582
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6565
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 24643997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)